Discontinuation report ZOFRAN ODT
Report ID | 187062 |
Drug Identification Number | 02239372 |
Brand name | ZOFRAN ODT |
Common or Proper name | ZOFRAN 4MG |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 4MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 1 X 10 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-02-06 |
Actual discontinuation date | 2023-03-06 |
Remaining supply date | 2025-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-03-14 | French | Compare |
v2 | 2023-03-14 | English | Compare |
v1 | 2023-03-14 | English | Compare |
Showing 1 to 3 of 3